Information  X 
Enter a valid email address
  Print          More announcements

Friday 11 June, 2021

Credit Suisse Cap.

Form 38.5b - Willis Towers Watson plc

RNS Number : 6654B
Credit Suisse Capital LLC
11 June 2021
 

Ap27

 

 

FORM   38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, 

OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

 Credit Suisse Capital LLC

Companydealtin

Willis Towers Watson Plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

Ordinary

Date of dealing

10th June 2021

 

 

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

209,566   0.15

 183,700  0.20

(2) Derivatives (other than options)

 

 

(3)Optionsandagreementstopurchase/sell

 

 

Total

209,566  0.15

 183,700  0.20

             

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   2)

 

Classofrelevantsecurity: Swap

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 

 

(2) Derivatives (other than options)

0   0

199,778  0.14

(3)Optionsandagreementstopurchase/sell

 

 

Total

0  0

199,778  0.14

             

Ap28

 

 

3.  DEALINGS  (Note   3)

 

(a)  Purchases and sales

 

Purchase/sale

Numberofrelevantsecurities

Priceperunit ( USD)

B

5

257.5

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 5)

Numberofrelevantsecurities

(Note 6)

Priceperunit

(Note 4) (USD)

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 4)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 4)

 

 

 

 

 

(d)  Other   dealings   (including   transactions   in   respect   of   new   securities)   (Note   3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

Ap29

 

4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any   other   person   relating   to   the   voting   rights   of   any   relevant   securities   under   any   option   referred   to  

on   this   form   or   relating   to   the   voting   rights  or future acquisition or disposal of any relevant securities 

to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached?  (Note   8)    NO

 

 

Dateofdisclosure

11th June 2021

 

Contactname

Anthony Allen / Paul MacDonald

Telephone number

0207 888 5416 / 8548

Name of offeree/offeror with which connected

Aon plc

Nature of connection (Note 9)

Advisor to Aon plc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEBFLFFFQLXBBF

a d v e r t i s e m e n t